Introduction Drug delivery across the blood-brain barrier (BBB) is challenging and therefore
severely restricts neurodegenerative diseases therapy such as Alzheimer's disease (AD) …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder associated with
memory and cognitive impairment. Donepezil is an acetylcholinesterase inhibitor used for …

Objective: Alzheimer's disease (AD) is a progressive neurodegenerative disorder
manifested by cognitive, memory deterioration and variety of neuropsychiatric symptoms …

Alzheimer's disease (AD) is the most common neurodegenerative disease, and is part of a
massive and growing health care burden that is destroying the cognitive function of more …

Alzheimer's disease (AD) is one of the most progressive neurodegenerative disorders
resulting in cognitive and behavioral impairment in individuals beyond 65 years of age. It is …

For the past several years, dementia, is one of the predominantly observed groups of
symptoms in a geriatric population. Alzheimer's disease (AD) is a progressive memory …

Neurodegenerative diseases (NDDs) have been increasing in incidence in recent years and
are now widespread worldwide. Neuronal death is defined as the progressive loss of …

Alzheimer's disease (AD) is the most common neurodegenerative disease worldwide and its
incidence is increasing due to the ageing population. Currently, the main limitations of AD …

As the globe's population increases, the incidences of Alzheimer's disease (AD) are steadily
increasing. AD represents the most common neurological disorder and constitutes 60–70 …

Therapeutic Delivery (2012) 3 (9) 1026 future science group hampering their biodistribution.
Conversely, ζ potential, an indicator of the repulsive force between particles, will influence …